EDGAR Filing Documents for 0001144204-09-020003

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0001144204-09-020003

Filing Date

2009-04-10

Accepted

2009-04-10 14:14:14

Documents

Period of Report

2008-06-30

Document Format Files

Seq	Description	Document	Type	Size
1		v145677_10ka.htm	10-K/A	2531619
2	GRAPHIC	str.jpg	GRAPHIC	46469
3		v145677_ex10-11.htm	EX-10.11	15982
4		v145677_ex31-1.htm	EX-31.1	11650
5		v145677_ex31-2.htm	EX-31.2	11692
6		v145677_ex32-1.htm	EX-32.1	7123
7		v145677_ex32-2.htm	EX-32.2	7098
	Complete submission text file	0001144204-09-020003.txt		2651107

Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075

Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880

Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)